An observational study in Postpartum Infectious Morbidity in Cesarean Section Delivery, sponsored by Raghda Gamal Mohamed. Status unknown. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-01-04.
Sponsored by Raghda Gamal Mohamed · Observational
This study aims to determine the effectiveness of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity and to assess potential maternal adverse effects and any impact on the infant.
4,452 studies on the registry are indexed under Communicable Diseases; 521 are open to participants now.
This study's planned enrollment of 200 is below the median of 244 across 1,499 observational studies indexed under Communicable Diseases.
Browse Communicable Diseases studies →This is the only study on the registry with Raghda Gamal Mohamed as lead sponsor.
Counted across the registry records on this site, refreshed daily.
women undergo cesarean section delivery whether elective or emergency
Exclusion Criteria:
role of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity
Time frame: 2 weeks following cesarean section
No study locations are listed for this record.
This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.